Intrexon | XON - Ebitda





Ebitda Perubahan Tanggal
Agenus USD -10.11M 19.02M 2025-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Amgen USD 5.14B 775M 2025-12
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD 57.17M 7.03M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Gilead Sciences USD 3.02B 1.01B 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
Heron Therapeutics USD -3.88M 5.63M 2024-09
Incyte USD 367.97M 46.53M 2026-03
Intrexon USD -24.7M 2.92M 2024-06
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD 66.78M 83.54M 2025-12
MacroGenics USD 21.95M 55.39M 2025-09
MannKind USD -3.05M 20.97M 2025-12
Merck USD 6.3B 2.09B 2025-12
Novartis USD 5.3B 530M 2026-03
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Roche Holding CHF 12.68B 2.36B 2024-06
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Veracyte USD 42.8M 488K 2026-03
Xencor USD -51.05M 55.28M 2025-12